A new model has projected a substantial rise in the burden of metabolic dysfunction-associated steatotic liver disease in the ...

Data from 22 studies, encompassing 756,088 subjects, including 62,072 Hispanic adults, revealed striking findings. The pooled ...

LONDON - RTW Biotech Opportunities Ltd (LSE: RTW), a London Stock Exchange-listed investment company, announced that its ...

Pegozafermin. It has two Phase 3 trials: one for MASH and the other for SHTG. See why I continue to rate ETNB stock a buy.

The American Gastroenterology Association (AGA) issued a new clinical guideline recommending antiviral drugs for patients at high risk for hepatitis B reactivation. (Gastroenterology) Researchers ...